ArticleMayo Clinic proceedings2016

Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs.

Chul Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.